Ion channel regulation of pancreatic islet cell function

离子通道对胰岛细胞功能的调节

基本信息

  • 批准号:
    10249948
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract It is estimated that 1 in 4 Veterans suffer from diabetes, and, in the Veteran population, this is largely Type 2 diabetes. This condition drives heart disease, stroke, retinopathy, nephropathy and neuropathy, all of which are a cause of significant morbidity and mortality among our Veterans. As such, understanding the biology of diabetes, discovering novel molecules that regulate b-cell function and developing innovative therapeutic approaches will have a significant impact on the health of our aging veteran population. Type 2 diabetes is characterized by both a loss of insulin sensitivity and, ultimately, a relative loss of insulin-secretion from the pancreatic b-cell. Insulin secretion from the pancreatic b-cell is triggered by Ca2+ influx through voltage-gated Ca2+ channels (VGCC) to trigger insulin vesicle fusion with the b-cell plasma membrane. We recently reported that SWELL1 (LRRC8a), a member of the Leucine Rich Repeat Containing protein family, is required for ICl,SWELL in β-cells. SWELL1-mediated ICl,SWELL activates upon b-cell swelling induced by glucose import, and this generates a depolarizing current contributing to VGCC activation, thereby regulating insulin secretion and systemic glycemia. Indeed, mice with SWELL1-deficient β-cells exhibit impaired glucose- stimulated insulin secretion and glucose intolerance. Moreover, we find that ICl,SWELL is reduced in both mouse and humans in the context of Type 2 diabetes (T2D) indicating that reduced SWELL1 signaling is associated with impaired b-cell function in T2D. The objective of the current proposal is to delineate the mechanisms by which SWELL1 signaling regulates b-cell function, under basal conditions, and in the setting of Type 2 diabetes. Our central hypothesis is that SWELL1 regulates both glucose-stimulated insulin secretion and PI3K-AKT-mTOR signaling in b-cells to maintain systemic glycaemia, and that impaired SWELL1 signaling contributes to b-cell failure in Type 2 diabetes. The contribution of this proposal is significant because it explores the innovative concept the SWELL1 utilizes dual signaling domains (channel versus LRRD) to regulate b-cell function in health and T2D. Importantly, this proposal will also define the relationship between b-cell SWELL1 and T2D and test the notion that reduced SWELL1 signaling may drive impaired b-cell function in T2D. We propose the following two AIMs: AIM#1: Delineate the mechanism(s) of SWELL1-mediated regulation of excitation-secretion coupling. AIM#2: Dissect the molecular mechanisms of SWELL1 macro-complex regulation of AKT-mTOR signaling in b-cells. The contribution of this proposal is innovative because it delineates a novel SWELL1 signaling pathway that connects glucose-mediated b-cell swelling to b-cell depolarization and insulin-release - a form of b-cell swell- activation or “swell-secretion” coupling. This proposal will enhance our understanding of b-cell biology and help direct novel therapeutic approaches to b-cell failure in Type 2 diabetes. !
项目总结/摘要 据估计,四分之一的退伍军人患有糖尿病,在退伍军人群体中,这主要是2型糖尿病。 糖尿病这种情况会导致心脏病、中风、视网膜病、肾病和神经病, 是我们退伍军人发病率和死亡率高的原因。因此,了解生物学 糖尿病,发现调节b细胞功能的新分子,开发创新的治疗方法 这些方法将对我们老年退伍军人的健康产生重大影响。2型糖尿病是 其特征在于胰岛素敏感性的丧失,并且最终,胰岛素分泌的相对丧失, 胰腺B细胞胰腺b细胞的胰岛素分泌是由Ca 2+通过电压门控的 Ca 2+通道(VGCC)触发胰岛素囊泡与b细胞质膜融合。 我们最近报道了SWELL 1(LRRC 8a),一个富含亮氨酸重复序列的蛋白, 家族,是β细胞中ICl、SWELL所必需的。SWELL 1介导的IC 1,SWELL在由 葡萄糖输入,并且这产生有助于VGCC激活的去极化电流,从而调节 胰岛素分泌和全身性炎症。事实上,SWELL 1缺陷β细胞的小鼠表现出葡萄糖代谢受损, 刺激胰岛素分泌和葡萄糖耐受不良。此外,我们发现,ICl,SWELL在两种小鼠中均降低, 2型糖尿病(T2 D)背景下的SWELL 1信号传导减少表明SWELL 1信号传导减少与糖尿病相关。 患有2型糖尿病的B细胞功能受损本提案的目的是通过以下方式界定这些机制: 在基础条件下和在类型2的设置中,SWELL 1信号传导调节b细胞功能 糖尿病我们的中心假设是SWELL 1调节葡萄糖刺激的胰岛素分泌, PI 3 K-AKT-mTOR信号在b细胞中维持系统性高血压,并损害SWELL 1 信号传导导致2型糖尿病中的b细胞衰竭。这项建议的贡献是重大的 因为它探索了创新的概念,SWELL 1利用双信令域(信道与 LRRD)调节健康和T2 D中的B细胞功能。重要的是,该提案还将界定 在b细胞SWELL 1和T2 D之间,并测试减少的SWELL 1信号传导可能驱动受损的b细胞 T2 D功能我们提出以下两个目标: 目标#1:描述SWELL 1介导的兴奋-分泌偶联调节机制。 目的#2:剖析SWELL 1宏观复合物调节AKT-mTOR的分子机制 B细胞中的信号。 这项提议的贡献是创新的,因为它描绘了一种新的SWELL 1信号通路, 将葡萄糖介导的b细胞肿胀与b细胞去极化和胰岛素释放(b细胞肿胀的一种形式)联系起来, 活化或“溶胀-分泌”偶联。该提案将增强我们对b细胞生物学的理解,并有助于 2型糖尿病患者的B细胞衰竭的新的治疗方法。 !

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rajan Sah其他文献

Rajan Sah的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rajan Sah', 18)}}的其他基金

SWELL1-LRRC8 mediated regulation of skeletal muscle function and metabolism
SWELL1-LRRC8 介导的骨骼肌功能和代谢调节
  • 批准号:
    10618270
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Optimizing small molecule SWELL1-LRRC8 modulators to treat Type 2 diabetes
优化小分子 SWELL1-LRRC8 调节剂治疗 2 型糖尿病
  • 批准号:
    10216501
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Optimizing small molecule SWELL1-LRRC8 modulators to treat Type 2 diabetes
优化小分子 SWELL1-LRRC8 调节剂治疗 2 型糖尿病
  • 批准号:
    10430129
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
SWELL1-LRRC8 mediated regulation of skeletal muscle function and metabolism
SWELL1-LRRC8 介导的骨骼肌功能和代谢调节
  • 批准号:
    10454421
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Optimizing small molecule SWELL1-LRRC8 modulators to treat Type 2 diabetes
优化小分子 SWELL1-LRRC8 调节剂治疗 2 型糖尿病
  • 批准号:
    10617838
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
SWELL1-LRRC8 mediated regulation of skeletal muscle function and metabolism
SWELL1-LRRC8 介导的骨骼肌功能和代谢调节
  • 批准号:
    10305237
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Ion channel regulation of pancreatic islet cell function
离子通道对胰岛细胞功能的调节
  • 批准号:
    10477248
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Ion channel regulation of pancreatic islet cell function
离子通道对胰岛细胞功能的调节
  • 批准号:
    10664931
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Tuning fat cell size and obesity through SWELL1
通过 SWELL1 调节脂肪细胞大小和肥胖
  • 批准号:
    9917773
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Tuning Adipocyte Size and Obesity through SWELL1
通过 SWELL1 调节脂肪细胞大小和肥胖
  • 批准号:
    10649660
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了